Abeona Therapeutics Inc (ABEO) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 30.50%11.38 | 8.72 | 5.42 | - | 0.40 |
| Cost Of Revenue | 54.93%4.18 | 2.70 | 1.04 | 0.49 | - |
18.80%15.84 | 19.50 | 18.78 | - | - | |
| Selling, General, and Administrative | 18.80%15.84 | 19.50 | 18.78 | - | - |
| Research and Development | 47.45%5.02 | 9.56 | 6.71 | - | - |
| Interest Income/Expense | 16.14%0.70 | 0.83 | 0.88 | 0.90 | 0.96 |
| Costs And Expenses | 21.16%25.03 | 31.75 | 28.33 | 24.02 | 23.19 |
| Depreciation and Amortization | 0.70 | 0.70 | 0.80 | 0.60 | 0.60 |
| Operating Income/Loss | 40.72%-13.65 | -23.03 | -22.91 | -24.02 | -22.79 |
| Nonoperating Income/Loss | 112.00%-0.01 | 0.05 | 0.05 | 0.13 | 0.09 |
| Income/Loss From Continuing Operations Before Tax | 18.26%-20.19 | -17.07 | -20.68 | -20.36 | 124.35 |
| Income Tax Expense/Benefit | 100.00%- | 0.00 | -0.22 | -15.20 | 15.51 |
18.25%-20.19 | -17.08 | -20.46 | -5.16 | 108.83 | |
| Attributable To Parent | 18.25%-20.19 | -17.08 | -20.46 | -5.16 | 108.83 |
| Basic Average Shares | 0.75%57.05 | 56.62 | - | 54.24 | 52.52 |
| Diluted Average Shares | 0.75%57.05 | 56.62 | - | 54.24 | 66.64 |
| Basic Earnings Per Share | 16.67%-0.35 | -0.30 | - | -0.10 | 2.07 |
| Diluted Earnings Per Share | 16.67%-0.35 | -0.30 | - | -0.10 | 1.71 |